ELV - Elevance Health, Inc.
Health CarePrice History
About
Company Overview
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.
Price
$292.75
52-Week Range
Dividend Yield
2.42%
Dividend Score
B
Dividend
Valuation
Profitability
Financial Health
Cash Flow
Analyst Consensus
20 analysts
Dividend Growth
Most Recent Annual Growth
4.91%
3-Year Avg Growth
10.22%
5-Year Avg Growth
12.58%
Annual Dividends
Year-over-Year Growth
Recent Dividend History
| Ex-Dividend Date | Amount |
|---|---|
| Mar 10, 2026 | $1.7200 |
| Dec 05, 2025 | $1.7100 |
| Sep 10, 2025 | $1.7100 |
| Jun 10, 2025 | $1.7100 |
| Mar 10, 2025 | $1.7100 |
| Dec 05, 2024 | $1.6300 |
| Sep 10, 2024 | $1.6300 |
| Jun 10, 2024 | $1.6300 |
| Mar 07, 2024 | $1.6300 |
| Dec 05, 2023 | $1.4800 |
| Sep 07, 2023 | $1.4800 |
| Jun 08, 2023 | $1.4800 |
| Mar 09, 2023 | $1.4800 |
| Dec 02, 2022 | $1.2800 |
| Sep 08, 2022 | $1.2800 |
| Jun 09, 2022 | $1.2800 |
| Mar 09, 2022 | $1.2800 |
| Dec 02, 2021 | $1.1300 |
| Sep 09, 2021 | $1.1300 |
| Jun 09, 2021 | $1.1300 |